During the three and nine months ended September 30, 2026, the Company awarded 592 and 301,041 shares of restricted stock awards (“RSAs”), respectively, to officers, employees, and non-employee directors under the Company’s equity incentive plan. During the three and nine months ended September 30, 2025, the Company awarded 1,180 and 317,156 shares of RSAs, respectively, to officers, employees, and non-employee directors under the Company’s equity incentive plan. The holder of RSAs is generally entitled at all times on and after the date of issuance of the restricted common shares to exercise the rights of a stockholder of the Company, including the right to vote the shares and the right to receive dividends on the shares. The RSAs vest over a one-, three-, four-, or five-year period from the date of the grant and are subject to the holder’s continued service through the applicable vesting dates and in accordance with the terms of the individual award agreements. The weighted average value of awards granted per share during the three and nine months ended September 30, 2026, were $22.40 and $19.37, respectively, which were based on the market price per share of the Company’s common stock on the grant dates. The weighted average value of awards granted per share during the three and nine months ended September 30, 2025, were $16.24 and $16.75, respectively.


	For the Three Months Ended September 30,
	2026			2025
(in thousands, except per share amounts)	Number of Shares	Weighted Average Grant Date Fair Value per Share		Number of Shares	Weighted Average Grant Date Fair Value per Share
Unvested at beginning of period	1,099	$	16.44	1,071	$	15.69
Granted	1	22.40		1	16.24
Vested	—	—		—	—
Forfeited	—	—		(1)	16.85
Unvested at end of period	1,100	$	16.45	1,071	$	15.69


	For the Nine Months Ended September 30,
	2026			2025
(in thousands, except per share amounts)	Number of Shares	Weighted Average Grant Date Fair Value per Share		Number of Shares	Weighted Average Grant Date Fair Value per Share
Unvested at beginning of period	1,070	$	15.69	989	$	15.51
Granted	301	19.37		317	16.75
Vested	(266)	16.70		(227)	16.36
Forfeited	(5)	16.62		(8)	16.60
Unvested at end of period	1,100	$	16.45	1,071	$	15.69

During the nine months ended September 30, 2026 and 2025, the Company issued target grants of 260,729 and 246,967 of performance-based restricted stock units (“PRSUs”), respectively, under the Company’s equity incentive plan to the executive officers of the Company. The awards are non-vested restricted stock units where the vesting percentages and the ultimate number of units vesting will be measured 50% based on the relative total shareholder return (“rTSR”) of the

Company’s common stock as compared to the rTSR of peer companies, as identified in the grant agreements, over a three-year period, and 50% based on the rTSR of the Company’s common stock as compared to the rTSR of the MSCI US REIT Index over a three-year measurement period. Vesting percentages range from 0% to 200% with a target of 100%. rTSR means the percentage appreciation in the fair market value of one share over the three-year measurement period beginning on the date of grant, assuming the reinvestment of dividends on the ex-dividend date. The target number of units is based on achieving a rTSR equal to the 55th percentile of the peer companies and MSCI US REIT Index. For PRSUs issued during the nine months ended September 30, 2026 and 2025 that achieve a percentile rank of at least the 55th percentile, and the absolute rTSR of the Company is negative for the performance period, the awards will be reduced by 25%, not to result in a reduction less than target. Recipients of PRSU awards issued during the nine months ended September 30, 2026 are eligible to receive additional PRSUs equal to additional 25% of their respective target awards if the absolute rTSR reaches 24%, and an additional 50% vesting if the rTSR reaches 36%, with linear interpolation if the rTSR is between 24% and 36%. Dividends accrue during the measurement period and will be paid on the PRSUs ultimately earned at the end of the measurement period in either cash or common stock, at the discretion of the Compensation Committee of the Board of Directors. The grant date fair value of the PRSUs was measured using a Monte Carlo simulation model based on assumptions including share price volatility.


	For the Three Months Ended September 30,
	2026			2025
(in thousands, except per share amounts)	Number of Shares	Weighted Average Grant Date Fair Value per Share		Number of Shares	Weighted Average Grant Date Fair Value per Share
Unvested at beginning of period	704	$	21.12	606	$	20.13
Granted	—	—		—	—
Vested	—	—		—	—
Forfeited	—	—		—	—
Unvested at end of period	704	$	21.12	606	$	20.13


	For the Nine Months Ended September 30,
	2026			2025
(in thousands, except per share amounts)	Number of Shares	Weighted Average Grant Date Fair Value per Share		Number of Shares	Weighted Average Grant Date Fair Value per Share
Unvested at beginning of period	606	$	20.13	433	$	20.90
Granted	261	25.09		247	21.12
Vested	(163)	23.78		(74)	27.93
Forfeited	—	—		—	—
Unvested at end of period	704	$	21.12	606	$	20.13

In July 2026, the Board of Directors amended the Company’s Non-Employee Director Compensation Policy to permit each non-employee director to elect to receive all or a portion of their annual cash retainers in the form of fully vested shares of the Company’s common stock, in lieu of cash, issued under the Company’s equity incentive plan. Retainers are paid quarterly in arrears, and share settlements will begin with the third quarter 2026 retainers, which will be paid in the fourth quarter of 2026. No shares had been issued under the policy as of September 30, 2026.